Image of Gail H Cassell

Gail H Cassell, Ph.D.

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

CPMAS NMR platform for direct compositional analysis of mycobacterial cell-wall complexes and whole cells.
Authors: Authors: Liu X, Brcic J, Cassell GH, Cegelski L.
J Magn Reson Open
View full abstract on Pubmed
Wastewater Surveillance Can Have a Second Act in COVID-19 Vaccine Distribution.
Authors: Authors: Smith T, Cassell G, Bhatnagar A.
JAMA Health Forum
View full abstract on Pubmed
AI for infectious disease modelling and therapeutics.
Authors: Authors: Alterovitz G, Alterovitz WL, Cassell GH, Zhang L, Dunker AK.
Pac Symp Biocomput
View full abstract on Pubmed
Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis Growth.
Authors: Authors: Ranjbar S, Haridas V, Nambu A, Jasenosky LD, Sadhukhan S, Ebert TS, Hornung V, Cassell GH, Falvo JV, Goldfeld AE.
iScience
View full abstract on Pubmed
The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus.
Authors: Authors: Jasenosky LD, Cadena C, Mire CE, Borisevich V, Haridas V, Ranjbar S, Nambu A, Bavari S, Soloveva V, Sadukhan S, Cassell GH, Geisbert TW, Hur S, Goldfeld AE.
iScience
View full abstract on Pubmed
A Spray-dried combination of capreomycin and cpzen-45 for inhaled tuberculosis therapy.
Authors: Authors: Pitner RA, Durham PG, Stewart IE, Reed SG, Cassell GH, Hickey AJ, Carter D.
J Pharm Sci
View full abstract on Pubmed
The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.
Authors: Authors: Baldwin SL, Larsen SE, Ordway D, Cassell G, Coler RN.
PLoS Negl Trop Dis
View full abstract on Pubmed
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.
Authors: Authors: Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE, Brand J, Chapman SB, Cho SN, Gabrielian A, Gomez J, Jodals AM, Joloba M, Jureen P, Lee JS, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati AA, Winglee K, Zalutskaya A, Via LE, Cassell GH, Dorman SE, Ellner J, Farnia P, Galagan JE, Rosenthal A, Crudu V, Homorodean D, Hsueh PR, Narayanan S, Pym AS, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai WR, Cohen T, Hoffner S, Birren BW, Earl AM.
Nat Genet
View full abstract on Pubmed
Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.
Authors: Authors: Malinga L, Brand J, Jansen van Rensburg C, Cassell G, van der Walt M.
Int J Mycobacteriol
View full abstract on Pubmed
Differential recognition of the multiple banded antigen isoforms across Ureaplasma parvum and Ureaplasma urealyticum species by monoclonal antibodies.
Authors: Authors: Aboklaish AF, Ahmed S, McAllister D, Cassell G, Zheng XT, Spiller OB.
J Microbiol Methods
View full abstract on Pubmed